Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes.
作者信息
Kruglikov Ilja L, Scherer Philipp E
机构信息
Scientific Department, Wellcomet GmbH, Karlsruhe, Germany.
Touchstone Diabetes Center, Department of Internal Medicine, Dallas, Texas, United States of America.
出版信息
PLoS Pathog. 2021 Feb 18;17(2):e1009306. doi: 10.1371/journal.ppat.1009306. eCollection 2021 Feb.
Abstract
摘要
相似文献
1
Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes.既往存在的和可诱导的内毒素血症是导致COVID-19病情严重程度的关键因素。
PLoS Pathog. 2021 Feb 18;17(2):e1009306. doi: 10.1371/journal.ppat.1009306. eCollection 2021 Feb.
2
Plasma concentrations of bacterial lipopolysaccharide: a marker of infection or inflammation?血浆中细菌脂多糖的浓度：感染还是炎症的标志物？
J Am Coll Cardiol. 2000 Aug;36(2):656-7. doi: 10.1016/s0735-1097(00)00750-6.
3
Into the looking glass: Post-viral syndrome post COVID-19.透过镜子：新冠病毒感染后的病毒后综合征
Med Hypotheses. 2020 Nov;144:110055. doi: 10.1016/j.mehy.2020.110055. Epub 2020 Jun 27.
4
[The influence of the surgical access on the endotoxemia level].[手术入路对内毒素血症水平的影响]
Khirurgiia (Mosk). 2013(1):39-42.
5
The impact of obesity on the cellular and molecular pathophysiology of COVID-19.肥胖对 COVID-19 的细胞和分子病理生理学的影响。
S Afr Med J. 2020 Dec 14;111(3):211-214. doi: 10.7196/SAMJ.2021.v111i2.15398.
6
7
Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects.墨西哥肥胖青少年的肠道微生物群与代谢性内毒素血症
Obes Facts. 2016;9(1):1-11. doi: 10.1159/000442479. Epub 2016 Jan 9.
8
Sinus bradycardia: an unusual manifestation of mild to moderate COVID-19 pneumonia.窦性心动过缓：轻度至中度新型冠状病毒肺炎的一种不寻常表现。
Tunis Med. 2020 Dec;98(12):886-887.
9
Risk factors for deterioration in mild COVID-19 remain undefined.轻度新冠肺炎病情恶化的风险因素仍不明确。
Emerg Med J. 2021 May;38(5):406. doi: 10.1136/emermed-2021-211233. Epub 2021 Mar 16.
10
Obesity and clinical severity in patients with COVID-19: a scoping review protocol.肥胖与 COVID-19 患者的临床严重程度：系统评价方案。
Syst Rev. 2021 Feb 7;10(1):51. doi: 10.1186/s13643-021-01603-x.
引用本文的文献
1
Regulation of the terminal complement cascade in adipose tissue for control of its volume, cellularity, and fibrosis.脂肪组织中终末补体级联反应的调节，以控制其体积、细胞组成和纤维化。
Obesity (Silver Spring). 2025 May;33(5):839-850. doi: 10.1002/oby.24270. Epub 2025 Mar 25.
2
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
3
Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine.解锁RNA测序在新冠病毒肺炎中的潜力：迈向精准诊断与个性化医疗
Diagnostics (Basel). 2025 Jan 20;15(2):229. doi: 10.3390/diagnostics15020229.
4
- and Pathogenic Bacteria-Derived Endotoxins Differently Regulate Human Dendritic Cell Generation and γδ T Lymphocyte Activation.并且病原细菌衍生的内毒素对人类树突状细胞生成和γδ T淋巴细胞活化的调节方式不同。
Biomolecules. 2024 Dec 9;14(12):1571. doi: 10.3390/biom14121571.
5
Haptoglobin buffers lipopolysaccharides to delay activation of NFκB.触珠蛋白缓冲脂多糖以延迟 NFκB 的激活。
Front Immunol. 2024 Oct 2;15:1401527. doi: 10.3389/fimmu.2024.1401527. eCollection 2024.
6
Intestinal Alkaline Phosphatase Activity and Efficiency Are Altered in Severe COVID-19 Patients.重症 COVID-19 患者肠道碱性磷酸酶活性及效能发生改变。
Gastro Hep Adv. 2023 Jul 17;2(7):911-917. doi: 10.1016/j.gastha.2023.07.003. eCollection 2023.
7
Contributions of the microbiota to the systemic inflammatory response.微生物群对全身炎症反应的作用。
Microbiota Host. 2023 Feb;1(1). doi: 10.1530/mah-23-0018. Epub 2023 Dec 18.
8
Is the endotoxin-complement cascade the major driver in lipedema?脂膜炎的主要驱动因素是内毒素-补体级联反应吗？
Trends Endocrinol Metab. 2024 Sep;35(9):769-780. doi: 10.1016/j.tem.2024.04.004. Epub 2024 Apr 29.
9
Nitrite Attenuates the In Vitro Inflammatory Response of Immune Cells to the SARS-CoV-2 S Protein without Interfering in the Antioxidant Enzyme Activation.亚硝酸盐可减轻免疫细胞对SARS-CoV-2 S蛋白的体外炎症反应，而不干扰抗氧化酶的激活。
Int J Mol Sci. 2024 Mar 5;25(5):3001. doi: 10.3390/ijms25053001.
10
Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation.解析 E1 修复受损心肌细胞：治疗意义及 H-FABP 作为心血管疾病和全身炎症的检测指标。
Prostaglandins Leukot Essent Fatty Acids. 2023 Oct;197:102586. doi: 10.1016/j.plefa.2023.102586. Epub 2023 Aug 10.
本文引用的文献
1
SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity.SARS-CoV-2 刺突蛋白与细菌脂多糖结合并增强促炎活性。
J Mol Cell Biol. 2020 Oct 12;12(12):916-932. doi: 10.1093/jmcb/mjaa067.
2
Endotoxemia and circulating bacteriome in severe COVID-19 patients.重症新型冠状病毒肺炎患者的内毒素血症与循环菌组
Intensive Care Med Exp. 2020 Dec 7;8(1):72. doi: 10.1186/s40635-020-00362-8.
3
Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease.血液微生物组和糖尿病及心血管疾病中的循环微生物代谢产物。
Trends Endocrinol Metab. 2020 Nov;31(11):835-847. doi: 10.1016/j.tem.2020.01.013. Epub 2020 Feb 11.
4
Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement.COVID-19 患者伴有心脏受累时，肠道渗漏和炎症小体激活的标志物升高。
J Intern Med. 2021 Apr;289(4):523-531. doi: 10.1111/joim.13178. Epub 2020 Oct 8.
5
Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions.肥胖和糖尿病作为 COVID-19 的合并症：潜在机制和病毒-细菌相互作用的作用。
Elife. 2020 Sep 15;9:e61330. doi: 10.7554/eLife.61330.
6
Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium.人肺上皮细胞中靶向 SARS-CoV-2 的 microRNA 的预测和分析。
Genes (Basel). 2020 Aug 26;11(9):1002. doi: 10.3390/genes11091002.
7
Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.COVID-19 超高炎症反应中循环细胞因子与白细胞自发性细胞因子产生之间的不匹配。
J Leukoc Biol. 2021 Jan;109(1):115-120. doi: 10.1002/JLB.5COVBCR0720-310RR. Epub 2020 Aug 13.
8
Pathogenetic profiling of COVID-19 and SARS-like viruses.COVID-19 和 SARS 样病毒的病原体特征分析。
Brief Bioinform. 2021 Mar 22;22(2):1175-1196. doi: 10.1093/bib/bbaa173.
9
The Role of Adipocytes and Adipocyte-Like Cells in the Severity of COVID-19 Infections.脂肪细胞和脂肪细胞样细胞在 COVID-19 感染严重程度中的作用。
Obesity (Silver Spring). 2020 Jul;28(7):1187-1190. doi: 10.1002/oby.22856. Epub 2020 Jun 10.
10
Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.2019-nCoV 感染后，小肠肠细胞中特定的 ACE2 表达可能导致胃肠道症状和损伤。
Int J Infect Dis. 2020 Jul;96:19-24. doi: 10.1016/j.ijid.2020.04.027. Epub 2020 Apr 18.
Zotero 插件